Biotech Series B Investors & VC Firms
12 firms in this list, with a median first check of $1M. 5 of them lead rounds. Generated from verified public data and updated continuously.
Madrona Venture Group
SeattlePre-Seed–Series C
Third Rock Ventures
BostonSeed–Series C
Lerer Hippeau
New YorkSeed–Series B
LSP (Life Sciences Partners)
StockholmSeries A–Late Stage$11M – $66M
Medicxi
LondonPre-Seed–Series C
Osage University Partners
Pre-Seed–Late Stage$1M – $20M
Innovestor Ventures
HelsinkiPre-Seed–Growth
Menlo Ventures
San FranciscoPre-Seed–Growth
Starfish Ventures
SydneySeed–Series B
Octopus Ventures
LondonPre-Seed–Late Stage$125K
DCVC (Data Collective)
San FranciscoSeed–Late Stage
Andreessen Horowitz
Menlo ParkSeed–Growth
Related lists
Series B Investors & VC Firms (68)Biotech Investors & VC Firms (21)Biotech Seed Investors & VC Firms (16)AI & Machine Learning Series B Investors & VC Firms (16)SaaS Series B Investors & VC Firms (12)Biotech Series A Investors & VC Firms (11)Fintech Series B Investors & VC Firms (10)Healthtech Series B Investors & VC Firms (10)Biotech Pre-Seed Investors & VC Firms (10)Climate Tech Series B Investors & VC Firms (10)
Data sourced from public filings and firms' own websites — see our methodology.